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ABSTRACT 
 
INTRODUCTION: Advanced machine learning methods might help to identify dementia risk from 
neuroimaging, but their accuracy to date is unclear.   
 
METHODS: We systematically reviewed the literature, 2006 to late 2016, for machine learning studies 
differentiating healthy ageing through to dementia of various types, assessing study quality, and comparing 
accuracy at different disease boundaries.  
 
RESULTS: Of 111 relevant studies, most assessed Alzheimer’s disease (AD) vs healthy controls, used 
ADNI data, support vector machines and only T1-weighted sequences. Accuracy was highest for 
differentiating AD from healthy controls, and poor for differentiating healthy controls vs MCI vs AD, or MCI 
converters vs non-converters. Accuracy increased using combined data types, but not by data source, 
sample size or machine learning method. 
 
DISCUSSION: Machine learning does not differentiate clinically-relevant disease categories yet. More 
diverse datasets, combinations of different types of data, and close clinical integration of machine learning 
would help to advance the field. 
 
Keywords: dementia, cerebrovascular disease, pathological aging, small vessel disease, MRI, machine 
learning, classification, segmentation.  
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INTRODUCTION 
Ageing is associated with increasing health care costs of which two related neurological disorders, dementia 
and stroke, account for much of the increase. Dementia is a progressive development of multiple cognitive 
deficits with several underlying aetiologies, the two commonest types being Alzheimer’s disease (AD) and 
vascular dementia (VaD). The total estimated worldwide cost of dementia was US$818 billion in 2015, 
representing 1.09% of global GDP.1 In 2015, 46.8 million people worldwide were living with dementia, a 
figure which is expected to almost double every 20 years, reaching 74.7 million in 2030 and 131.5 million by 
2050. Meanwhile, stroke remains the second commonest cause of death and commonest cause of 
dependency in adults worldwide.2   
 
Age-related cognitive decline ranges from minor reductions in memory and executive function that do not 
interfere with daily life, to more severe degrees that fall short of dementia but may interfere with some 
activities of daily living, termed ‘mild cognitive impairment’. Mild cognitive impairment (MCI) may progress to 
dementia or remain static, and cognitive decline is also a risk factor for stroke. 
 
All three of MCI, dementia and stroke are associated with changes seen on brain imaging particularly brain 
volume loss (atrophy) and development of focal lesions in the white and grey matter such as white matter 
hyperintensities (WMH), lacunes, microbleeds, focal cortical or subcortical infarcts or small haemorrhages. 
These features are also associated with ageing (though are less frequent in healthy ageing), may be 
symptomatic or asymptomatic, and predict increased risk of stroke, dementia and death.3  
 
In the last decade, improvements in medical imaging, higher image quality, the exponential increase in 
computational power of affordable computing platforms, and the greater availability of brain imaging 
datasets such as from the Alzheimer’s Disease Neuroimaging Initiative (ADNI), have increased 
opportunities to develop machine learning approaches aimed at the automated detection, classification and 
quantification of diseases.4 Some of these techniques have been applied to classify brain magnetic 
resonance imaging (MRI) or computed tomography (CT) scans, comparing patients with dementia and 
healthy controls and to distinguish different types or stages of dementia, cerebrovascular disease and 
accelerated features of aging. However, the recent rapid increase in publications using different machine 
learning techniques in different populations, types of images and disease criteria, make it difficult to obtain 
an objective view of the current accuracy of machine learning. 
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We undertook this systematic review to critically appraise the accuracy of machine learning to differentiate 
healthy ageing from mild cognitive impairment from dementia and predict the future risk of dementia or 
cerebrovascular disease. We evaluated the performance metrics of individual machine learning techniques 
by task, disease of interest, imaging sequence and features investigated.  
 
 
METHODS 
 
Search Strategy 
We searched the literature from 1st Jan 2006 (when first publications on machine learning in the disorders 
of interest started appearing in earnest) to 30th September 2016, on six databases: Pubmed/Medline, 
Elsevier, IEEE Xplore Digital Library, Science Direct, ACM Digital Library and Web of Science.  
 
We devised three groups of keywords, each relevant to different aspects of the scope of the review: 
Brain lesions and relevant pathologies: Dement*,  Alzheimer,  AD, VCI, VaD, small vessel disease, SVD, 
microvascular change, cognitive impairment, cognitive decline, MCI, Lewy bod*, LBD, frontotemporal, FTD, 
lacun*, white matter hyperintens*, white matter lesion*, WMH, leukoaraiosis, periventricular, microbleed*, 
microhaemorr*, microhemorr*, stroke, cerebrovascular, CVA, perivascular space*, PVS, Virchow–Robin 
space*, pathological aging, pathological ageing, brain, cerebr*, medial temporal, mesial temporal, volume 
loss, atrophy. 
Machine learning: machine learning, supervised learning, unsupervised learning, deep learning, 
classification, identification, detection, automat* diagnosis, pattern analysis, CAD, computer aided 
diagnosis, computer assisted diagnosis, computational analysis. 
Structural imaging: MR, magnetic resonance, structural imag*, CT, CAT, computed tomograph*.  
 
We searched titles, abstracts and keyword fields of indexed studies, published as journal papers or 
conference proceedings, with all possible strings obtained by joining one term from each of the above 
groups with an ”AND” operator. One reviewer (EP) conducted the searches and eliminated all duplicate 
references. 
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Inclusion/Exclusion Criteria  
Two reviewers (EP, VGC) separately assessed all non-duplicate papers in a two-stage selection process. 
First, we evaluated titles and abstracts to exclude studies clearly not relevant to the scope of the review. 
Second, we assessed full texts of the remaining papers to eliminate studies using the following exclusion 
criteria: 
1. Studies of animals or ex-vivo samples 
2. Reviews, surveys, collections and comparison papers not presenting a new ML method or application. 
3. Studies with a validation set comprising a small number of subjects (<100 for disease classification or 
lesion identification tasks, and <25 for pixel or voxel level lesion segmentation tasks) or with a manual 
ground truth provided by only one trained observer. 
4. Studies presenting a method in which the main task (e.g., lesion segmentation) was not performed in a 
fully automated fashion. Studies involving semi-automated pre-processing steps (e.g., brain parcellation 
refinement) obtained by making use of previously validated software and trained observers were accepted. 
5. Studies not about structural MRI or CT imaging. 
6. Studies focused on image pre-processing techniques that did not include any machine learning for 
disease classification or lesion segmentation/identification (e.g., contrast enhancement, noise reduction 
techniques, etc.). 
7. Studies of parcellation of healthy brain regions not used for disease classification or detection. 
8. Studies that either did not provide, or presented their results in such a way that we were not able to 
calculate performance metrics (e.g. sensitivity and specificity). 
9. Multiple publications from the same research group, focusing on the same task and dataset. In such 
cases, only the most recent publication or with the largest sample size was included in the data analysis. 
10. Studies that did not describe their methods in sufficient detail to enable replication. 
 
Discrepancies were resolved by discussion between the two reviewers with a third (MvH, LB, GM) 
arbitrating as necessary. 
 
 Data Extraction 
From the included papers, we extracted data on the: 
(1) disease or lesion investigated,  
(2) dataset used and whether it was publicly available or not,  
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(3) number of subjects or images on which the proposed technique had been validated,  
(4) type of structural imaging modality  and sequences used,  
(5) imaging features that were investigated,  
(6) use of any additional imaging data (e.g., functional imaging) or non-imaging features (e.g., cognitive test 
scores) in the analysis,  
(7) classifier(s) and the feature selection and representation techniques used, and  
(8) performance (sensitivity, specificity, accuracy) of the proposed method.  
We extracted data to calculate sensitivity and specificity where not already calculated. 
If multiple tasks were investigated in a single study, the respective data for each experiment were recorded. 
We also extracted (when reported) details of: use of single vs multiple scanners, image resolution, 
population demographics, exclusion criteria for each dataset, image pre-processing steps, time cost, and 
use of third party software (details available on request). 
 
We evaluated study quality according to the relevant Quality Assessment of Diagnostic Accuracy Studies 2 
(QUADAS-2) criteria ([https://www.ncbi.nlm.nih.gov/pubmed/22007046). We used the seven criteria that 
were most relevant to the material of the review, four addressing risk of bias and three addressing 
applicability. since some criteria were not strictly applicable to the field. 
 
All acronyms used in the results table are reported in Supplemental Table 1. 
 
Data Analysis 
We extracted the different performance metrics directly from the papers, or calculated them from the data 
provided. In particular, we aimed to examine: 
1. Sensitivity, specificity and accuracy for binary classification tasks. 
2. Mean class accuracy for multi-class classification tasks. 
3. Dice coefficient (DC) for accuracy of lesion segmentation tasks. 
4. Precision and recall for lesion identification tasks (calculated using the formula in Supplementary 
methods). 
Where the results of multiple experiments for the same classification task were reported in a single study, 
we only used the set of metrics associated with the higher value of accuracy in our analysis. 
We constructed forest plots to summarise sensitivity, specificity, accuracy and 95% confidence intervals 
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(CI) of various clinically relevant diagnoses including AD versus healthy ageing, MCI versus AD or healthy 
ageing, MCI conversion to AD versus not conversion. In order to summarise the mass of information 
effectively, we plotted forest plots of accuracy rather than sensitivity and specificity, defined as:  
 
 
 
We performed sensitivity analyses to determine if source dataset, machine learning method, type of data 
used, or study size accounted for the variance between studies. We calculated 95% CI of accuracy using 
the Wilson score method. We plotted all graphs in R. We considered but rejected performing a formal meta-
analysis, since the huge overlap in datasets in publications precluded determining the results of patients 
who contributed to more than one study (even with exclusion of obvious duplicate publications), preventing 
the modelling of between-study variance. Finally, to minimise confounding by inclusion of studies that only 
contributed to one comparison, we compared accuracy across multiple diagnostic boundaries using studies 
that provided data on more than one diagnostic comparison from the same dataset. 
 
Role of the Funding Source 
The funders had no role in the conduct of this systematic review. The corresponding author confirms that 
she had full access to all the data in the study and had final responsibility for the decision to submit for 
publication. 
 
 
RESULTS 
Our search yielded 5775 non-duplicate studies, of which 4978 (86%) were excluded at title/abstract 
screening as clearly not relevant to the review. After full text screening, we found 111 papers relevant for 
data extraction (Figure 1). The two criteria accounting for the most exclusions were small sample (item 3) 
and no performance metrics provided or calculable (item 8; respectively 41% and 19% of exclusions at this 
stage; proportions meeting exclusion criteria see Supplementary Table 2). Note that studies that failed one 
exclusion criterion were excluded and not evaluated further; although some might have failed on multiple 
criteria, we only recorded the first reason for exclusion. 
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Most of the 111 studies that met inclusion criteria achieved low risk of bias scores and low concerns on 
applicability (Supplement Figure 1). Of the 111, we used 89 studies in further analyses of accuracy where 
data could be extracted as 2x2 tables and there were sufficient studies to compare.  
 
 
Figure 1 Flowchart of search and exclusion stages of the review. 
 
 
Most studies tested the diagnosis of AD (68/89, 76%), most versus healthy controls (67/89, 75%), then MCI 
non-converters to AD versus converters to AD (37/89, 42%), MCI versus healthy controls (29/89, 33%), and 
MCI versus AD (8/89, 9%; Table 1 shows individual comparisons; full details in Supplementary Table S3).  
There were 21 studies that compared multiple diagnostic classes, of which many involved the same author 
groups.  
 
The remaining studies focused on other factors: other types of dementia (five studies, Supplementary Table 
S4), and studies investigating different types of brain lesions related to dementia, stroke and pathological 
aging, either: lesion segmentation (seven studies, Supplementary Table S5) or lesion identification (11 
studies, Supplementary Table S6). As there were few eligible studies in the latter three categories, it was 
not possible to undertake any formal comparisons, e.g. of DICE coefficients (for WMH, ischaemic stroke 
lesions), Precision or Recall values (for microbleeds, lacunes). However the DICE coefficients for WMH 
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segmentation (four studies, mean n=81, range 38-125) ranged from 0.520-0.691 and for infarcts (three 
studies, mean n=42, range 30-60) ranged from 0.670-0.740 (Supplementary Table S5). The 
Precision/Recall values for microbleeds (three studies, mean n=66, range 50-81) for Precision were 0.101-
0.443 and for Recall were 0.870-0.986; there was one study on lacunes (n=132) with Precision of 0.154 and 
Recall of 0.968 (Supplementary Table S6).  
 
 
 
 
 
 
 
 
 
 
Data sources HC v AD HC v MCI MCInc v 
MCIc 
MCI v AD Total 
ADNI 54 24 34 7 119 
ADNI + Bdx-3C 0 0 1 0 1 
AddNeuroMed 1 0 2 0 3 
AddNeuroMed + ADNI 2 1 1 0 4 
Local 4 3 0 0 7 
OASIS 7 2 0 1 10 
Total 68* 30 38 8 144 
Machine learning method      
AdaBoost 1 0 1 0 2 
Deep Learning 2 2 0 0 4 
Gaussian Process 0 0 1 0 1 
LDA 5 0 5 1 11 
Logistic Regression 4 0 2 0 6 
OPLS 2 1 1 0 4 
QDA 0 0 1 0 1 
RBF-NN 0 0 1 0 1 
Random Forest 3 1 3 0 7 
SRC 2 1 2 0 5 
SVM 39 22 17 7 85 
SVM + MKL 3 1 1 0 5 
SVM + OPLS 1 0 1 0 2 
SVM + Random Forest 2 1 2 0 5 
SVM + SRC 1 1 0 0 2 
kNN 3 0 0 0 3 
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Total 68* 30 38 8 144 
Types of Imaging and imaging plus non-
imaging data used 
     
T1w only 46 13 26 6 91 
T1w & other imaging data 8 8 2 0 18 
T1w & other types of data 8 3 8 1 20 
T1w & both other imaging & types of data 6 6 2 1 15 
Total 68* 30 38 8 144 
Size of dataset (range from 100 to 902 
participants). 
     
150 and under 30 4 9 2 45 
151 to 200 4 10 6 0 20 
201 to 250 9 4 6 0 19 
251 to 300 4 2 3 0 9 
Over 300 21 10 14 6 51 
Total 68* 30 38 8 144 
 
Table 1 Number of comparisons in each systematic review analysis group using specified data source, 
machine learning method, types of imaging and non-imaging data and by study size. Individual studies 
contribute to more than one analysis and use more than one data source, machine learning method, 
combinations of imaging data and more than one dataset (hence more than one sample size in some 
studies). HC=healthy control; AD=Alzheimer’s disease; MCI=mild cognitive impairment; nc=non converter to 
AD; c=converter to AD. 
 
 
The 76 analyses focused on AD (Supplementary Table S3) amounted to 68 unique references, with huge 
overlap in authors and data sources between the studies. As well as using more than one data source, 
many studies performed more than one comparison of disease classifications with these multiple data 
sources, hence amounting to 144 different comparisons (Table 1). Of the 144 comparisons, there were 120 
uses of ADNI data (ADNI alone 119/144, 83%; ADNI plus other 120/144, 83%), followed by Oasis (10/144, 
7%), local sources (7/144, 5%), and AddNeuroMed (alone 3/144, 2%; plus ADNI 4/144, 3%).  
 
The 76 analyses of AD tested nine different machine learning methods. The most frequent, by a large 
margin, was Support Vector Machine (SVM) with 46/76 (61%) alone and 53/76(70%) combined with another 
machine learning method, then linear discriminant analysis (LDA, 6/76,  8%), logistic regression (4/76,  5%) 
and a few testing k-nearest neighbours (KNN), Orthogonal Projections to Latent Structures (OPLS), 
Random forest, or Sparse Representation Classification (SRC), Table 1. Most analyses, by a large margin, 
used only T1 images (91/144, 63%), with modest numbers using T1 plus other sequences, other types of 
data, or both.  Analysis sample sizes ranged from 100 to 902, with similar numbers of analyses including 
more than 300 subjects (51/144, 35%) or fewer than 150 subjects (45/144, 31%), Table 1.   
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Amongst the 76 studies focused on AD, the accuracy was higher for differentiating AD from healthy controls 
(most study accuracies were in the 0.8-1.0 range), than for differentiating MCI from healthy controls 
(accuracies =0.6-0.9), or non-converting from converting MCI to AD (accuracies= 0.5-0.85), or MCI from AD 
(accuracies =0.6-0.9). Figure 2a-d indicates the lower accuracy for differentiating healthy controls from MCI, 
or MCI from AD, or MCI non-converters from converters, than healthy controls from AD; Supplementary 
Figures 2-4 illustrate these same comparisons ordered by data source, machine learning method and study 
size respectively. There was little evidence of any difference in accuracy by machine learning method, data 
source used, or study size, with possible higher accuracy for combined T1 plus other sequences and other 
types of data than for T1 imaging alone.  
 
 
 
 
 
A 
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Figure 2. Differentiation of a) healthy controls from AD, b) of HC from MCI, c) of MCI converters from non-
converters and d) of MCI from AD, ordered according to type of data used: T1W only, T1W+other 
sequences, T1W+non-imaging data, and T1W+other sequences+non-imaging data. 
 
Finally, restricting comparisons of accuracy to studies that examined more than one diagnostic 
classification (Figure 3a-d), clearly demonstrates the lower accuracy for differentiating between healthy 
controls and MCI, or MCI from AD, or either healthy controls or AD and MCI converting/non converting, 
from healthy controls or AD (Figure 3 a-d). 
 
 
 
 
 
 
 
 
 
13 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
14 
 
Figure 3 Studies which included more than one diagnostic classification. Top Left. Healthy controls 
versus MCI and Healthy controls vs AD, Top Right. Healthy controls v MCI converting and MCI 
converting v MCI non-converting Bottom Left. MCI converting v MCI non-converting and MCI v AD, 
Bottom Right, Healthy controls v AD and MCI v AD 
 
 
DISCUSSION 
We found acceptable accuracy for all machine learning methods in differentiating healthy controls from AD, 
but fewer data and lower accuracies for differentiating healthy controls from MCI, or MCI from AD, or (of 
more concern) for risk prediction of MCI non-converters from converters to AD. From a clinical perspective, 
the comparison of healthy controls to AD is the least important distinction: such Type I diagnostic studies do 
not aim to produce clinically relevant estimates of sensitivity and specificity, but to test the initial feasibility of 
a method. While the results for machine learning methods in differentiating healthy controls from AD are 
encouraging, the performance across the other cognitive diagnosis categories indicates that the field has 
some way to go before these methods should enter routine clinical use.4 The over-reliance on one data 
source, one type of imaging, and one machine learning method, further limits the clinical relevance and 
generalisability of the results. This may reflect that, as yet, machine learning is still insufficiently intertwined 
with the clinical world, in part due to misalignment of targets and methods: while the machine learning 
community aims primarily for algorithm novelty, inspired largely by computer vision and machine learning, 
clinicians want reliable, validated, methods for early diagnosis, risk prediction, or monitoring interventions, 
that are better than conventional methods, and change clinical practice. 
 
We aimed to include as many relevant papers as possible, so kept the search broad. We retained 
conference papers to reflect the tendency to publish conference papers that equate to full publications in 
the fast-moving medical image analysis, computer vision and machine learning fields. High-quality 
conference papers are at least as selective as many journals; e.g., MICCAI, a leading medical image 
analysis conference, applies a 3-stage selection protocol including rebuttal. About a quarter (29/111, 26%) 
of the included papers were conference papers. The number of un-refereed pre-prints becoming available 
online (e.g., arXiv, biorXiv) is also increasing rapidly, but we did not include these pre-print publications 
since they are not peer-reviewed. However, the use of these sites for dissemination is growing and may 
need considering in future reviews. The proportion of papers using deep learning has increased since late 
2016 (including several published by the authors, many conference papers in MIUA 2018, and MICCAI 
2017), and therefore this review may under-represent the most recent developments in machine learning. 
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However, many of these recent papers focused on methods to detect single brain lesion types, such as 
WMH or atrophy, that are associated with cognitive decline but not on degrees of cognitive decline itself, or 
on differentiating AD from healthy controls rather than more subtle diagnoses. Therefore it is unlikely that 
the conclusions of the present analysis, which is based on a substantial body of work, would change by the 
inclusion of these most recent papers. 
 
Some non-systematic reviews and surveys on machine learning have been published.5-11 We used 
established systematic review methods including QUADAS-2 criteria to grade study quality, since there are 
no agreed guidelines for reviews in data science and machine learning, but found the QUADAS criteria 
difficult to apply. We aimed to make reasonable exclusion criteria (publications from 2006 onward, data set 
larger than 100 for patient/image level classification, data set larger than 25 for pixel/voxel level 
segmentation), based on experience and consultation with a team of experts. We do not believe that the 
main conclusions would change significantly by including more small studies, and believe that the main 
messages embedded in the current literature are captured well by the review.  
 
We excluded more than 200 papers (Supplementary Table S2) because the sample size or ground truth 
annotations were too small. This suggests the need for more public data repositories with annotated, 
reliable data. Various international initiatives provide public annotated data sets for competitions, e.g. the 
challenges organized by MICCAI or ISBI. Such challenges emphasize the competition aspect (achieving 
the best values for specific performance parameters), more than maximizing the amount of data made 
available, the generalisability of the results, or relevance to clinical practice. The latter two should receive 
more attention if the field is to advance. 
 
We excluded many papers that did not provide accuracy data. This suggests a need to standardise 
reporting of performance criteria, an issue in the validation of algorithms and software for data and image 
analysis.12-14 Some aspects of the perceived importance of standard criteria and data sets is highlighted by 
the clear majority of papers using the ADNI data set (www.adni-info.org). Although use of one dataset may 
promote cross-comparisons of results, it is likely to inflate estimates of accuracy and considerably reduces 
the generalisability of the results to clinical practice. Deep learning techniques are rapidly becoming the 
methods of choice in medical image analysis, and feature in increasing proportions in conferences and 
journals, e.g. many conference papers at MIUA 2017. However, the overall message remains the same, i.e. 
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differentiation of AD from healthy controls, but fewer studies and poorer accuracy at differentiating MCI vs. 
healthy control or AD, or MCI converters/non-converters to AD, with the same problems of sample size and 
repeated use of the same data and lack of clinical integration. This further increases the need for large 
datasets as convolutional neural networks have millions of parameters to train. The performance of systems 
classifying brain images as associated with AD or not seems to improve when taking into consideration 
multiple data types.15, 16 Including non-imaging features, like CSF biomarkers and cognitive test scores, 
unsurprisingly also improve performance. Further work is needed to clarify the interplay between data from 
images and from other sources.17 
 
Most studies started with pre-processed features (‘ground truth’) as input to the machine learning method. 
Many pre-processing techniques use population templates that derive from young populations; these are of 
limited relevance to the older brain and may bias the resulting machine learning outputs.17 Very few papers 
on lesion segmentation techniques were included as most failed the inclusion criteria on annotations 
(ground truth). This reflects that generating sufficient ground truth for a reliable validation of such algorithms 
is very time consuming, and highlights a limitation of machine learning methods in relying on ground truth. 
Use of crowd-sourcing to annotate images may be one solution but would have to achieve high reliability to 
meet the definition of ‘ground truth’;18-20 their use remains sub judice and depends on the application. We 
also notice recent work on the automatic generation of annotations (auto-annotations) for non-medical 
classifiers with large numbers of classes,21 and the growing interest of medical image analysts in 
techniques to minimise the number of annotations required without affecting performance.22 
 
It proved particularly difficult to locate papers attempting stratification of different types of dementia, and few 
studies combined imaging with other data types. Possible reasons include that diagnosing dementia is not a 
clear-cut process, so that several covariates should be considered in addition to a binary label (dementia/no 
dementia), e.g. time of diagnosis, source data for diagnosis (MCI test, brain images, clinical records, 
prescriptions). Different dementia components might be present at the same time. Finally, to our best 
knowledge, no public data sets exist which offer reliably stratified, sufficiently large cohorts with brain 
imaging. 
 
Practically all the included papers were written for a computer science or engineering audience. They 
focused on technical information (e.g. algorithm choice and description, parameter setting techniques, 
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training protocol) omitting essential clinically-relevant information (e.g. patient and cohort demographics, 
clinical covariates, data acquisition protocols). Clearly, specialized journals and conferences require 
specialist language, but international efforts are needed to make technical papers more understandable to a 
clinical audience, and vice versa, to improve interdisciplinarity. 
 
CONCLUSIONS 
The results of our review indicate that machine learning methods to predict risk of dementia are not yet 
ready for routine use. There is a need to push inter-disciplinary collaborations, including the development of 
internationally agreed (by clinicians and computer science/engineers) validation protocols and clinical trials. 
The further development of any machine learning methods in neuroimaging requires much greater 
interdisciplinary working, use of varied and clinically-relevant public data sets with annotations, or ground 
truth, including a variety of imaging types not just T1, to maximise the use of relevant predictive variables 
and ensure that the resulting machine learning methods are robust and reliable prior to further testing in 
clinical trials in patients. 
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Methods 
Calculation of the precision and recall for lesion identification tasks  
Precision and Recall are defined as: 
  
 
 
where: tp= true positive (indicates accurate lesion identification) 
tn=true negative (indicates correct rejection of non-lesion tissue) 
fp=false positive (indicates identification of a lesion that is not there) 
fn=false negative (indicates failure to identify a lesion that is present)  
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Table S1. Acronyms used in Tables listing study results. 
 
Acronym Definition 
AD Alzheimer’s Disease 
AdaBoost Adaptive Boosting 
ADAS-Cog Alzheimer’s Disease Assessment Scale - cognitive subtest 
ADNI Alzheimer’s Disease Neuroimaging Initiative 
APOE3 Apolipoprotein E 
BoW Bag of Words 
CCA Canonical Correlation Analysis 
CDR-SB Clinical Dementia Rating - Sum of Boxes 
CMB Cerebral Microbleeds 
CSF Cerebrospinal Fluid 
DLB Dementia with Lewy Bodies 
DTI Diffusion Tensor Imaging 
DWT Discrete Wavelet Transform 
FA Fractional Anisotropy 
FAQ Functional Activities Questionnaire 
FDG Fluorodeoxyglucose 
FDR Fisher Discriminant Ratio 
FF-NN Feed Forward Neural Network 
FLAIR Fluid Attenuated Inversion Recovery 
fMRI functional Magnetic Resonance Imaging 
FS Feature Selection 
FTD Frontotemporal Dementia 
GM Gray Matter 
GRE Gradient Recalled Echo 
HC Healthy Control 
HMM Hidden Markov Model 
ICV Intracranial Volume 
kNN k-Nearest Neighbours 
LASSO Least Absolute Shrinkage and Selection Operator 
LBP Local Binary Patterns 
LDA Linear Discriminant Analysis 
MABMIS Multi-Atlas based Multi-Image Segmentation 
MCI Mild Cognitive Impairment 
MCIc Mild Cognitive Impairment (converting) 
MCIe Mild Cognitive Impairment (early amnestic) 
MCInc Mild Cognitive Impairment (non-converting) 
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MD Mean Diffusivity 
MIL Multiple Instance Learning 
MKL Multiple Kernel Learning 
MMSE Mini-Mental State Examination  
mRMR minimum Redundancy Maximum Relevance 
MTI Magnetization Transfer Imaging 
NN Neural Network 
OASIS Open Access Series of Imaging Studies 
OPLS Orthogonal Projections to Latent Structures 
PCA Principal Component Analysis 
PD Proton Density 
PDF Probability Distribution Function 
PESFAM Probabilistic Ensemble Simplified Fuzzy ARTMAP 
PET Positron Emission Tomography 
P-NN Probabilistic Neural Network 
QDA Quadratic Discriminant Analysis 
QDC Quadratic Discriminant Classifier 
RAVENS Regional Analysis of Volumes Examined in Normalized Space 
RAVLT Rey’s Auditory Verbal Learning Test 
RBF Radial Basis Function 
RFE Recursive Feature Elimination 
ROI Region Of Interest 
SAE Stacked Auto Encoders 
SES Socioeconomic Status 
SRC Sparse Representation Classification 
SVD Small Vessel Disease 
SVM Support Vector Machine 
SWI Susceptibility-Weighted Imaging 
TIA Transient Ischemic Attack 
VBM Voxel-Based Morphometry 
WM White Matter 
WML White Matter Lesions  
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Table S2. Details of reason for rejection and proportions 
 
Rejection criteria Number of rejected studies (%) 
1. Animals or ex-vivo. 1 (0.2) 
2. Review, survey, collection. 27 (5.3) 
3. Size of the dataset, number of observers. 209 (40.7) 
4. Semi-automatic technique. 61 (11.9) 
5. No structural imaging. 25 (4.9) 
6. Pre-processing technique. 12 (2.3) 
7. Healthy region parcellation. 13 (2.5) 
8. Non-comparable results 96 (18.7) 
9. ”Multiple” publications. 63 (12.3) 
 10. Non-reproducible 7 (1.4) 
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Table S3. Machine learning studies that classified AD or MCI and healthy controls 
Reference Dataset Classification Image  features Additional imaging Classifiers Results 
    tasks (n) (FS  and  representation) sequences and  features     
(Aggarwal, Rana et al. 2015) OASIS HC  vs AD (99 / 99) 3D-DWT (symmlet) of  7  ROI’s:    hip- n.a. kNN Sen = 0.789 / Spe = 0.810 
      pocampus, amygdalae, ventricles, an-       
      terior and   posterior cingulate (FS   by       
      FDR and mRMR).       
(Aguilar, Westman et al. 2013) AddNeuroMed HC  vs AD (110 / 116) 68     cortical    thickness    values      and Education. SVM  (non-lin) Sen = 0.862 / Spe = 0.900 
    MCInc vs MCIc  (98 / 21) 50   regional  volumes  obtained   with n.a. OPLS Sen = 0.810 / Spe = 0.684 
      FreeSurfer.       
(Ahmed, Mizotin et al. 2015) ADNI HC  vs AD (162 / 137) Circular  harmonic features extracted n.a. SVM  (RBF) Sen = 0.791 / Spe = 0.882 
    HC  vs MCI  (162 / 210) from hippocampus and  posterior cingu-     Sen = 0.626 / Spe = 0.748 
    AD vs MCI  (210 / 137) late  cortex (FS by PCA; BoW represen-     Sen = 0.490 / Spe = 0.752 
      tation)       
(Anagnostopoulos, Giannoukos et al. 2013) AddNeuroMed HC  vs MCI  vs AD Cortical volume  and  thickness for spe- T2w, demographics. Ensemble  of Acc = 0.771 
   (113 / 122 / 123) cific  ROI’s,   manual  volume   measure-   FF-NN, SVM,   
      ment of the  hippocampus.   PESFAM,   
          P-NN, kNN   
(Archana and Ramakrishnan 2014) OASIS HC  vs AD (92 / 45) Voxel-wise  texture features from  struc- n.a. SVM Sen = 0.877 / Spe = 0.849 
    HC  vs MCI  (92 / 67) ture tensor analysis (FS  by FDR).     Sen = 0.764 / Spe = 0.783 
    AD vs MCI  (67 / 45)       Sen = 0.747 / Spe = 0.767 
(Babu, Suresh et al. 2013) ADNI HC  vs MCIc  (232 / 167) Voxel-wise  GM  probability values  from n.a. RBF-NN Sen = 0.730 / Spe = 0.840 
    MCInc vs MCIc  (236 / 167) VBM analysis (FS by t-test).     Sen = 0.880 / Spe = 0.890 
(Beheshti, Demirel et al. 2015) ADNI HC  vs AD (130 / 130) Voxel-wise  GM  probability values  from n.a. SVM  (RBF) Sen = 0.908 / Spe = 0.908 
      VBM   analysis  (FS   based   on  PDF  of       
      ROI’s).       
(Casanova, Hsu et al. 2013) ADNI HC  vs AD (188 / 171) Voxel-wise   intensities  from  GM,   WM n.a. Regularized Sen = 0.843 / Spe = 0.890 
    HC  vs MCInc (188 / 182) and CSF  maps. n.a. logistic Sen = 0.586 / Spe = 0.681 
    HC  vs MCIc  (188 / 153)   n.a. regression Sen = 0.740 / Spe = 0.881 
    MCInc vs MCIc  (182 / 153)   Cognitive scores.   Sen = 0.579 / Spe = 0.701 
(Chaddad, Desrosiers et al. 2016) OASIS HC  vs AD (62 / 62) 3D co-occurrence matrix. n.a. Random forest. Sen = 0.742 / Spe = 0.759 
(Chen and Pham 2013) OASIS HC  vs AD (75 / 75) 2D  regularity  information  from  semi- n.a. HMM Sen = 0.800 / Spe = 0.800 
      variogram analysis of GM  maps.       
(Chen, Wei et al. 2015) ADNI MCInc vs MCIc  (167 / 236) GM  volumes in 93 ROI’s  (sparse repre- n.a. SRC Sen = 0.581 / Spe = 0.763 
      sentation).       
(Chincarini, Bosco et al. 2011) ADNI HC  vs AD (189 / 144) Voxel  intensities of filtered masks  in  9 n.a. Random Sen = 0.890 / Spe = 0.940 
    HC  vs MCIc  (189 / 136) ROI’s:  hippocampi, amygdalae. middle   forest  + SVM Sen = 0.890 / Spe = 0.800 
    MCInc vs MCIc  (166 / 136) and  inf temp gyri,  rolandic.     Sen = 0.720 / Spe = 0.650 
(Cho, Seong et al. 2012) ADNI HC  vs AD (80 / 66) Cortical thickness values (FS by PCA). n.a. LDA Sen = 0.820 / Spe = 0.930 
    HC  vs MCIc  (80 / 35)       Sen = 0.660 / Spe = 0.890 
    MCInc vs MCIc  (66 / 35)       Sen = 0.630 / Spe = 0.760 
(Costafreda, Dinov et al. 2011) AddNeuroMed MCInc vs MCIc  (81 / 22) Thickness values  of hippocampi. n.a. SVM  (RBF) Sen = 0.770 / Spe = 0.800 
(Coupé, Fonov et al. 2015) ADNI MCInc vs MCIc  (309 / 37) SNIPE  (Scoring  by   Nonlocal  Image n.a. LDA Sen = 0.649 / Spe = 0.735 
      Patch   Estimator)   hippocampal  fea-       
      tures.       
(Cui, Wen et al. 2012) Local HC  vs MCI  (204 / 79) 10 regional volumes from  T1w,  58 WM DTI. SVM  (RBF) Sen = 0.520 / Spe = 0.784 
      integrity features from  DTI.       
(Cuingnet, Gerardin et al. 2011) ADNI HC  vs AD (80 / 66) Voxel-wise   GM   probability  values   in n.a. SVM  (linear) en = 0.810 / Spe = 0.950 
    HC  vs MCIc  (80 / 35) ROI’s   defined   by  different  processing     Sen = 0.680 / Spe = 0.950 
    MCInc vs MCIc  (66 / 35) pipelines.     Sen = 0.570 / Spe = 0.780 
(Cuingnet, Glaunes et al. 2013) ADNI HC  vs AD (81 / 68) GM,  WM  and  CSF  probability maps, n.a. SVM  (non-lin) Sen = 0.880 / Spe = 0.930 
      cortical    thickness    values     (FS     by       
      anatomical and  spatial priors in SVM).       
(Davatzikos, Bhatt et al. 2011) ADNI MCInc vs MCIc  (85 / 35) Pattern of  atrophy  in  GM   and   WM CSF biomarkers. SVM  (non-lin) Sen = 0.842 / Spe = 0.512 
      maps.       
(Ding, Zhang et al. 2015) ADNI HC  vs AD (58 / 54) 8  GM  volumes in  ROI’s,   220  texture n.a. SVM Sen = 0.870 / Spe = 0.983 
      features,  64  features  from   2D  multi-       
      scale  Gabor filtering (FS  by RFE).       
(Dubey, Zhou et al. 2014) ADNI HC  vs AD (191 / 138) Cortical  thickness  values,  volumes  of n.a. Random forest Sen = 0.826 / Spe = 0.906 
    HC  vs MCI  (191 / 319) cortical  ROI’s,    volumes   of   WM    in   SVM Sen = 0.793 / Spe = 0.493 
    HC  vs AD+MCIc (191 / 280) ROI’s,  total surface  area  of the  cortex   SVM Sen = 0.879 / Spe = 0.825 
      (FS by sparse  logistic  regression).       
(Dyrba, Ewers et al. 2012) Local HC  vs AD (143 / 137) GM   probability  map   values    (FS   by n.a. SVM  (RBF) Sen = 0.874 / Spe = 0.912 
      entropy-based information gain).       
(Eskildsen, Coupé et al. 2013) ADNI HC  vs AD (226 / 194) Cortical thickness values  (FS  by  t-test Age. LDA Sen = 0.794 / Spe = 0.889 
    MCInc vs MCIc  (227 / 161) and  mRMR).     Sen = 0.658 / Spe = 0.683 
(Eskildsen, Coupé et al. 2015) ADNI MCInc vs MCIc  (238 / 167) L  / R  hippocampal grading,  cortical Age. LDA Sen = 0.696 / Spe = 0.736 
      thickness values  of 3 ROI’s  (FS  by mu-       
      tual  information method).       
(Filipovych, Davatzikos et al. 2011) ADNI HC  vs AD (63 / 54) GM  RAVENS map  (FS  by RFE). n.a. SVM  (linear, Sen = 0.796 / Spe = 0.857 
    MCInc vs MCIc  (174 / 68)     semi-supervised) Sen = 0.794 / Spe = 0.517 
(Granziera, Daducci et al. 2015) Local HC  vs MCI  (77 / 42) Volume  and  mean  intensity values  from MTI, T2*. SVM Sen = 0.600 / Spe = 0.830 
      7  ROI’s   (WM   and   cortical GM,   tha-       
      lamus, caudate, globus  pallidus, puta-       
      men   and   hippocampus)  and   for  WM       
      and  GM  of each  lobe.       
(Gray, Aljabar et al. 2013) ADNI HC  vs MCI  (35 / 75) 83 ROI  volumes from  GM  maps, voxel PET, APOE3, Random Sen = 0.775 / Spe = 0.679 
      intensities from  PET. CSF biomarkers. forest   
(Guerrero, Wolz et al. 2014) ADNI HC  vs AD (175 / 106) Voxel  intensities (Laplacian eigenmaps n.a. SVM  (linear) Sen = 0.860 / Spe = 0.850 
  ADNI-GO MCInc vs MCIc  (114 / 116) representation after  FS  by  Elastic Net     Sen = 0.750 / Spe = 0.670 
    HC  vs MCIc  (175 / 116) and  manifold learning).     Sen = 0.860 / Spe = 0.760 
    HC  vs MCIe  (134 / 229)       Sen = 0.610 / Spe = 0.690 
(Herrera, Rojas et al. 2013) ADNI HC  vs AD (443 / 459) 2D-DWT (Db4   and   Haar) multi-scale n.a. SVM  (RBF) Sen = 0.963 / Spe = 0.961 
    HC  vs MCI  vs AD (443 features (FS  by PCA and  mutual infor-     Acc = 0.774 
    / 448 / 459) mation method).       
(Hinrichs, Singh et al. 2009) ADNI HC  vs AD (94 / 89) GM  probability maps  (FS  by  t-test to n.a. Linear Sen = 0.850 / Spe = 0.800 
      select relevant voxels).   programming   
(Hinrichs, Singh et al. 2011) ADNI HC  vs AD (66 / 48) GM  probability maps  (FS  by  t-test to PET, APOE3, MKL Sen = 0.867 / Spe = 0.966 
      select relevant voxels). CSF  biomarkers,     
        cognitive scores.     
(Hor and Moradi 2016) ADNI HC  vs MCIc  (178 / 96) Volume    measurements  of   six   ROI’s n.a. Random Sen = 0.691 / Spe = 0.844 
    HC  vs MCInc (178 / 126) (ventricles, hippocampus, whole-brain, n.a. forest Sen = 0.734 / Spe = 0.863 
    HC  vs MCInc (18 / 144) entorhinal, fusiform  and  mid-temporal) PET.   Sen = 0.737 / Spe = 0.897 
    MCInc vs MCIc  (126 / 96) and  ICV from T1w,  FDG  and  AV45 up- n.a.   Sen = 0.819 / Spe = 0.750 
    MCInc vs MCIc  (144 / 27) take  values  from  PET (FS  by  informa- PET.   Sen = 0.831 / Spe = 0.803 
      tion  gain).       
(Hu, Wang et al. 2016) ADNI HC  vs AD (228 / 188) 3D-DWT (Gabor and  Haar) multi-scale n.a. SVM  (linear) Sen = 0.846 / Spe = 0.855 
    MCInc vs MCIc  (62 / 71) features from GM of map  of hippocam-     Sen = 0.718 / Spe = 0.823 
      pus.       
(Illan, Garriz et al. 2014) ADNI HC  vs AD (76 / 63) Binary values   of GM,  WM  maps  in  6 n.a. SVM  (ensemble) Sen = 0.926 / Spe = 0.845 
    HC  vs MCIc  (76 / 110) ROI’s:  parahippocampal gyrus,  lingual     Sen = 0.773 / Spe = 0.845 
      gyrus,  hippocampus, frontal lobe,  pre-       
      central gyrus,  temporal lobe  (Bayesian       
      network representation).       
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Reference Dataset Classification Image  features Additional imaging Classifiers Results 
    tasks (n) (FS  and  representation) sequences and  features     
(Jiang and Shi 2014) ADNI HC  vs AD  (52 / 51) 83 ROI  volumes from  GM  maps (FS  by n.a. kNN Sen  = 0.920  / Spe  = 0.904 
      sparse kernel  entropy component  anal-       
      ysis).       
(Jie, Zhang et al. 2014) ADNI HC  vs AD  (52 / 51) GM  volumes and  PET intensity values PET, MKL Sen  = 0.947  / Spe  = 0.958 
    HC  vs MCI  (52 / 99) in 93 ROI’s(FS by manifold regularized CSF biomarkers.   Sen  = 0.894  / Spe  = 0.708 
      multitask learning method).       
(Khedher, Ramirez et al. 2015) ADNI HC  vs AD  (229  / 188) Voxel  intensities in GM  and  WM  maps n.a. SVM  (linear) Sen  = 0.913  / Spe  = 0.851 
    HC  vs MCI  (229  / 401) (FS  by  partial least  square).     Sen  = 0.822  / Spe  = 0.816 
    MCI  vs AD  (401  / 188)       Sen  = 0.870  / Spe  = 0.838 
(Komlagan, Ta et al. 2014) ADNI MCInc vs MCIc  (236  / 166) SNIPE   (Scoring  by   Nonlocal  Image n.a. SVM  (linear) Sen  = 0.615  / Spe  = 0.856 
      Patch Estimator) hippocampal features       
      (FS  by  sparse logistic  regression).       
(Korolev, Symonds et al. 2016) ADNI MCInc vs MCIc  (139  / 120) Cortical thickness, volumes, curvature Risk  factors, MKL Sen  = 0.834  / Spe  = 0.764 
      and  surface area   of  180  ROI’s  (FS  by cognitive scores,     
      joint mutual information criterion). proteomic data.     
(Krashenyi, Ramirez et al. 2016) ADNI HC  vs AD  (229  / 188) Mean  ROI  intensity values of GM  and PET. Fuzzy inference Sen  = 0.933  / Spe  = 0.922 
    HC  vs MCI  (229  / 401) WM  maps from  T1w  and  mean inten-   system. Sen  = 0.759  / Spe  = 0.861 
    MCI  vs AD  (401  / 188) sity  from  PET (FS  by t-test).     Sen  = 0.749  / Spe  = 0.820 
(Lebedev, Westman et al. 2014) ADNI HC  vs AD  (75 / 35) Volumes   from    41   ROI’s    and    corti- APOE3, Random Sen  = 0.920  / Spe  = 0.886 
    MCInc vs MCIc  (130  / 35) cal  thickness  values (FS  by  PCA and demographics. forest. Sen  = 0.833  / Spe  = 0.813 
      RFE).       
(Li, Wang et al. 2010) OASIS HC  vs MCI  (80 / 89) GM  values in  19  ROI’s   (FS   by  t-test MMSE. SVM  (RBF) Sen  = 0.919  / Spe  = 0.880 
      and feature ranking).       
(Li, Liu et al. 2014) ADNI MCIc  vs MCInc (161  / 132) Cortical  thickness  values,  volumes  of Demographics, Random Sen  = 0.667  / Spe  = 0.814 
      cortical  ROI’s,    volumes   of   WM    in genetic data, forest   
      ROI’s,  total surface area  of the  cortex cognitive scores,     
      (FS  by  hierarchical Lasso  method). lab  tests.     
(Li, Oishi et al. 2014) ADNI HC  vs AD  (142  / 80) Voxel-wise   combination    of    2D-LBP n.a. SVM Sen  = 0.804  / Spe  = 0.827 
    MCInc vs MCIc  (142  / 141) from axial, coronal and  sagittal orienta-     Sen  = 0.615  / Spe  = 0.635 
      tions  (FS  by  t-test and  a priori knowl-       
      edge).       
(Li, Yan et al. 2015) ADNI HC  vs AD  (60 / 60) Volume and  15 texture features from  4 n.a. SVM  (RBF) Sen  = 0.927  / Spe  = 0.973 
    HC  vs MCI  (60 / 60) structures (GM, WM,  CSF, hippocam-     Sen  = 0.804  / Spe  = 0.864 
      pus)  in L / R hemispheres (FS by chain-       
      like agent genetic algorithm).       
(Liu, Suk et al. 2013) ADNI HC  vs AD  (198  / 198) Volume and  cortical thickness from  68 n.a. SVM Sen  = 0.894  / Spe  = 0.950 
    HC  vs MCI  (198  / 198) ROI’s  (sparse representation and  high-   (multi-kernel) Sen  = 0.778  / Spe  = 0.854 
      order graph matching for FS).       
(Liu, Tosun et al. 2013) ADNI HC  vs MCIc  (138  / 97) Values  of  volume  from   94  ROI’s   and n.a. Logistic Sen  = 0.650  / Spe  = 0.630 
    HC  vs MCInc (138  / 93) cortical thickness from  68 ROI’s  (repre-   regression Sen  = 0.810  / Spe  = 0.820 
    HC  vs AD  (138  / 86) sentation by local  linear embedding FS     Sen  = 0.860  / Spe  = 0.930 
    MCInc vs MCIc  (93 / 97) by  Elastic Net).     Sen  = 0.800  / Spe  = 0.560 
    MCInc vs AD  (93 / 86)       Sen  = 0.770  / Spe  = 0.730 
    MCIc  vs AD  (97 / 86)       Sen  = 0.560  / Spe  = 0.610 
(Liu, Zhang et al. 2013) ADNI HC  vs AD  (229  / 198) Voxel-wise GM  probability values (reg- n.a. SVM  (linear) Sen  = 0.853  / Spe  = 0.943 
    HC  vs MCInc (229  / 236) ularized  tree-structured   approach  for     Sen  = 0.801  / Spe  = 0.922 
    MCInc vs MCIc  (236  / 167) sparse learning).     Sen  = 0.562  / Spe  = 0.809 
(Liu, Zhou et al. 2014) ADNI HC  vs AD  (70 / 50) 126  hippocampal shape features and CSF biomarkers. MKL Sen  = 0.933  / Spe  = 0.875 
      GM  volumes from  100  ROI’s/ (FS  by       
      LASSO).       
(Liu, Liu et al. 2015) ADNI HC  vs AD  (204  / 180) Values  of  volume  from   T1w   and   of n.a. Deep Sen  = 0.868  / Spe  = 0.778 
    HC  vs MCI  (204  / 374) metabolic rate of glucose  consumption n.a. learning Sen  = 0.495  / Spe  = 0.843 
    HC  vs MCInc vs MCIc  vs AD from  PET in  83  ROI’s  (FS  by  Elastic n.a. (SAE) Acc = 0.463 
    (204  / 214 / 160 / 180) Net).     Sen  = 0.923  / Spe  = 0.904 
    HC  vs AD  (77 / 85)   PET   Sen  = 0.600  / Spe  = 0.923 
    HC  vs MCI  (77 / 169)   PET   Acc = 0.538 
    HC  vs MCInc vs MCIc  vs AD   PET     
    (77 / 102 / 67 / 85)         
(Liu, Cai et al. 2016) ADNI HC  vs MCI  vs AD  (77 / 169 / 85) GM   Volume,  local  gyrification index, PET. SVM ACC  = 0.6535 
      convexity and  solidity ratios from  T1w,   (multi-kernel)   
      mean index, fuzzy  index, 3 difference-       
      of-Gaussian features  from   PET in  83       
      ROI’s.       
(Liu, Zhang et al. 2016) ADNI HC  vs AD  (128  / 97) ROI  average values from  different tem- n.a. SVM  (ensemble) Sen  = 0.928  / Spe  = 0.957 
    MCInc vs MCInc (117  / 117) plates of GM  density maps (FS  and  en-     Sen  = 0.860  / Spe  = 0.784 
      coding  by  subclass clustering).       
(Luchtenberg, Simões et al. 2014) OASIS HC  vs AD  (66 / 70) Dissimilarity matrix of  voxel  intensity n.a. kNN Sen  = 0.800  / Spe  = 0.880 
      histograms.       
(Martinez-Torteya, Treviño et al. 2015) ADNI MCI  vs AD  (86 / 24) GM  volume in 90 ROI’s,  cortical thick- PET, CSF LDA Sen  = 0.476  / Spe  = 0.941 
      ness  in 139 ROI’s  from  T1w,  metabolic biomarkers, APOE3,     
      rate of glucose  consumption from  PET plasma, biological     
      (FS  by genetic models and  Pearson cor- samples.     
      relation coefficients).       
(Martinez-Murcia, Gorriz et al. 2016) ADNI HC  vs AD  (180  / 180) LBP features from  GM  and  WM  maps n.a. SVM  (linear) Sen  = 0.899  / Spe  = 0.919 
      (2D  representation of the  brain and  FS       
      by  t-test).       
(McEvoy, Fennema-Notestine et al. 2009) ADNI HC  vs AD  (139  / 84) Morphometric measures from  58 ROI’s. n.a. LDA Sen  = 0.830  / Spe  = 0.930 
(Moradi, Pepe et al. 2015) ADNI MCInc vs MCIc  (100  / 164) Voxel-wise  GM  density  values (FS   by Age,  RAVLT, Random Sen  = 0.870  / Spe  = 0.740 
      regularized logistic  regression). ADAS-Cog, MMSE, forest  +   
        CDR-SB, FAQ. SVM  (RBF)   
(Morgado and Silveira 2015) ADNI HC  vs AD  (75 / 59) Voxel-wise   GM    density   values  (FS n.a. SVM Sen  = 0.869  / Spe  = 0.872 
    HC  vs MCI  (75 / 135) by Minimal Neighborhood Redundancy     Sen  = 0.688  / Spe  = 0.670 
      Maximal Relevance).       
(Nho, Shen et al. 2010) ADNI HC  vs AD  (226  / 182) GM  density values from  86 ROI’s,  cor- APOE3, SVM  (RBF) Sen  = 0.850  / Spe  = 0.948 
    HC  vs MCI  (226  / 355) tical  thickness values from 56 ROI’s  (FS family history.   Sen  = 0.694  / Spe  = 0.698 
      by  SVM-RFE).       
(Plocharski and Østergaard 2016) ADNI HC  vs AD  (96 / 109) Depth,  length,  curvature  and   surface n.a. SVM  (linear) Sen  = 0.900  / Spe  = 0.867 
      area   of  24  sulci  (FS  by  forward  selec-       
      tion).       
(Rao, Lee et al. 2011) Local HC  vs AD  (60 / 69) Voxel-wise  GM  density  values (FS   by n.a. Logistic Sen  = 0.904  / Spe  = 0.803 
      spatially regularized formulation).   regression   
(Rueda, Gonzalez et al. 2014) OASIS HC  vs MCI  + AD  (98 / 100) Voxel  intensities (graph-based saliency n.a. MKL Sen  = 0.670  / Spe  = 0.735 
      map representation).       
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Reference Dataset Classification Image  features Additional imaging Classifiers Results 
    tasks  (n) (FS  and  representation) sequences  and  features     
(Savio and GrañA 2013) OASIS HC vs AD (316 / 100) Voxel   intensities  (represented  as  the n.a. SVM (RBF) Sen = 0.856 / Spe = 0.863 
      trace    of   the   Jacobian   matrix   from       
      tensor-based   morphometry   analysis.       
      FS by t-test).       
(Schmitter, Roche et al. 2015) ADNI HC vs AD (276 / 221) Volumes,   obtained from  FreeSurfer or n.a. SVM Sen = 0.860 / Spe = 0.910 
    HC vs MCI (276 / 401) MorphoBox of: total GM, left and right     Sen = 0.690 / Spe = 0.830 
    MCI vs AD (401 / 221) temporal GM, left and right hippocam-     Sen = 0.690 / Spe = 0.670 
    MCInc  vs MCIc  (103 / 137) pus, total CSF, and lateral, 3 and 4 ven-     Sen = 0.750 / Spe = 0.660 
      tricles.       
(Schouten, Koini et al. 2016) Local HC vs AD (173 / 77) GM  density  values  in 110 ROI’s,  WM DTI, fMRI. Regularized Sen = 0.826 / Spe = 0.927 
    HC vs AD mild (173 / 39) density   values  in  20 ROI’s  from  T1w.   logistic Sen = 0.721 / Spe = 0.935 
    HC vs AD moderate FA and MD values  in 20 ROI’s.   2415   regression Sen = 0.813 / Spe = 0.956 
    (173 / 38) values   of  correlation  from   functional       
      connectivity analysis  from fMRI (FS by       
      Elastic Net).       
(Shi, Suk et al. 2014) ADNI HC vs AD (52 / 51) GM volumes  and  PET intensity values PET SVM (linear) Sen = 0.942 / Spe = 0.969 
    HC vs MCI (52 / 99) in 93 ROI’s (FS  by Lasso).   SRC Sen = 0.817 / Spe = 0.762 
(Singh, Fletcher et al. 2014) ADNI MCInc  vs MCIc  (73 / 54) Anatomical  shape   variations  with   re- PET, APOE3, QDA Sen = 0.942 / Spe = 0.969 
      spect   to   atlas    (FS   by   partial  least CSF biomarkers.   Sen = 0.817 / Spe = 0.762 
      square model).       
(Spulber, Simmons et al. 2013) AddNeuroMed, HC vs AD (52 / 51) Volumes  of 23 ROI’s and cortical  thick- PET OPLS Sen = 0.861 / Spe = 0.904 
  ADNI HC vs MCI (52 / 99) ness values  of 34 ROI’s.     Sen = 0.696 / Spe = 0.668 
(Suk, Lee et al. 2015) ADNI HC vs AD (52 / 51) GM  volumes   and   PET  intensity val- PET, SVM Sen = 0.920 / Spe = 0.980 
    HC vs MCI (52 / 99) ues in 93 ROI’s  (FS  by  deep  weighted CSF biomarkers.   Sen = 0.939 / Spe = 0.908 
    HC vs MCI vs AD(229  / subclass-based sparse  multi-task learn-     Acc = 0.577 
    403 / 198) ing approach).       
    HC vs MCInc  vs MCIc  vs AD       Acc = 0.478 
    (229 / 236 / 167 / 198)         
(Tong, Wolz et al. 2014) ADNI HC vs AD (231 / 198) Voxel  intensity  from  a  variable  num- n.a. SVM Sen = 0.849 / Spe = 0.926 
    HC vs MCIc  (231 / 167) ber K of patches (MIL approach, FS by     Sen = 0.689 / Spe = 0.931 
    MCInc  vs MCIc  (238 / 167) Elastic Net).     Sen = 0.665 / Spe = 0.731 
(Varol, Gaonkar et al. 2012) ADNI HC vs AD (148 / 116) Voxel-wise   density   values   from   GM, n.a. SVM (ensemble) Sen = 0.862 / Spe = 0.897 
      WM and ventricles maps (FS by t-test).       
(Vemuri, Gunter et al. 2008) ADNI HC vs AD (50 / 50) Voxel-wise   density   values   from   GM, Demographics, SVM (linear) Sen = 0.860 / Spe = 0.920 
      WM   and   CSF   maps   (FS   by  feature APOE3.     
      ranking).       
(Wachinger and Reuter 2016) ADNI HC vs MCI vs AD (129 / 122 / 103) Cortical  thickness values  in  70 ROI’s, n.a. Multinomial Acc = 0.590 
      volumes  of 39 ROI’s  and  58 shape  fea-   regression   
      tures. (FS  by Elastic  Net).       
(Wang, Jia et al. 2012) ADNI HC vs AD (229 / 199) GM,  WM  CSF  values  in 54 ROI’s  ob- n.a. SVM (linear) Sen = 0.861 / Spe = 0.918 
    MCI vs AD (404 / 199) tained from  MABMIS  pipeline  (FS  by     Sen = 0.403 / Spe = 0.870 
    HC vs MCI (229 / 404) t-test).     Sen = 0.794 / Spe = 0.881 
    MCInc  vs MCIc  (236 / 168)       Sen = 0.667 / Spe = 0.723 
(Wang, Du et al. 2015) ADNI HC vs MCI (52 / 99) GM volumes  and  PET intensity values PET, SVM (linear) Sen = 0.827 / Spe = 0.473 
      in 93 ROI’s (FS  by PCA). CSF biomarkers.     
(Wee, Yap et al. 2012) ADNI HC vs AD (200 / 198) Cortical thickness, GM  and  WM  vol- n.a. SVM (RBF, Sen = 0.904 / Spe = 0.943 
    HC vs MCI (200 / 200) umes  in 68 ROI’s.  Correlative features   multi-kernel) Sen = 0.836 / Spe = 0.840 
    MCI vs AD (200 / 198) between   pairs  of ROI’s  (FS  by  t-test,     Sen = 0.780 / Spe = 0.805 
    MCInc  vs MCIc  (111 / 89) mRMR  and  SVM-RFE).     Sen = 0.635 / Spe = 0.844 
(Wei, Li et al. 2016) ADNI MCInc  vs MCIc  (83 / 76) Cortical thickness, volume,  and cortical n.a. SVM (RBF) Sen = 0.684 / Spe = 0.759 
      surface area in 68 ROI’s.  136 nodal fea-       
      tures  from the thickness network(FS by       
      regularized sparse  linear  regression).       
(Westman, Simmons et al. 2011) AddNeuroMed, HC vs AD (335 / 295) Cortical   thicknessin   in   57   selected n.a. OPLS Sen = 0.834 / Spe = 0.878 
  ADNI MCInc  vs MCIc  (353 / 84) ROI’s and  volumes  of 23 ROI’s.     Sen = 0.714 / Spe = 0.601 
(Wolz, Julkunen et al. 2011) AddNeuroMed, HC vs AD (231 / 198) Hippocampal volume, cortical  thickness n.a. LDA Sen = 0.930 / Spe = 0.850 
  ADNI HC vs MCIc  (231 / 167) from  different  ROI’s,   84  tensor-based     Sen = 0.860 / Spe = 0.820 
    MCInc  vs MCIc  (238 / 167) morphometry and  20 manifold  learning     Sen = 0.670 / Spe = 0.690 
      features (FS  by t-test).       
(Xie, Cui et al. 2015) Local HC vs MCI (64 / 64) Voxel-wise  value  of GM from T1w  and DTI. SVM (linear, Sen = 0.786 / Spe = 0.888 
      FA and  MD from DTI  (FS  by t-test).   ensemble)   
(Xu, Wu et al. 2015) ADNI HC vs AD (117 / 113) GM volumes  from T1w and uptake val- PET (FDG and SRC Sen = 0.956 / Spe = 0.940 
    HC vs MCI (117 / 110) ues  from  PET in  90  ROI’s  (FS  by  t- Florbetapir).   Sen = 0.664 / Spe = 0.821 
    MCInc  vs MCIc  (83 / 27) test).     Sen = 0.741 / Spe = 0.815 
(Yang, Li et al. 2014) ADNI HC vs AD (150 / 70) Voxel-wise  values  from  GM  map  (ICA MMSE, SVM Sen = 0.992 / Spe = 0.962 
    HC vs MCI (150 / 98) decomposition and  FS by t-test). GDTOTAL,   Sen = 0.860 / Spe = 0.896 
        HMSCORE.     
(Ye, Pohl et al. 2011) ADNI MCInc  vs MCIc  (169 / 68) GM  RAVENS map  (graph representa- n.a. SVM (linear Sen = 0.941 / Spe = 0.408 
      tion  and  FS by ISOMAP).   Laplacian,   
          semi-supervised)   
(Ye, Zu et al. 2015) ADNI HC vs AD (52 / 51) GM  volumes   and   PET  intensity val- PET. SVM (linear, Sen = 0.947 / Spe = 0.971 
    HC vs MCI (52 / 99) ues  in  93 ROI’s  (FS  by  discriminative   multi-kernel) Sen = 0.877 / Spe = 0.715 
      multi-task approach).       
(Young, Modat et al. 2013) ADNI MCInc  vs MCIc  (96 / 47) GM volumes  and  PET intensity values PET, APOE3. Gaussian Sen = 0.787 / Spe = 0.656 
      in 920 ROI’s.   process   
(Zhang, Wang et al. 2011) ADNI HC vs AD (52 / 51) GM volumes  and  PET intensity values PET, SMV (linear, Sen = 0.930 / Spe = 0.933 
    HC vs MCI (52 / 99) in 93 ROI’s. CSF biomarkers. multi-kernel) Sen = 0.818 / Spe = 0.660 
(Zhang, Wang et al. 2015) OASIS HC vs MCI vs AD 3D-DWT decomposition features, ICV, Demographics, SMV (RBF) Acc = 0.815 
    (97 / 57 / 24) atlas   scaling  factor,   normalized brain Education,     
      volume (FS  by PCA.) SES, MMSE.     
(Zhang and Wang 2015) OASIS HC vs AD (98 / 28) Voxel-wise   displacement   field   values PET, APOE3. SVM (twin) Sen = 0.906 / Spe = 0.934 
      (direction and  magnitude) of key T1w       
      slices.  (FS by PCA.)       
(Zhang, Stonnington et al. 2016) ADNI HC vs AD (228 / 194) Hippocampal surface tensor-based mor- n.a. Adaboost Sen = 0.830 / Spe = 0.780 
    MCInc  vs MCIc  (246 / 142) phometry features and  radial  distance     Sen = 0.820 / Spe = 0.760 
      (FS  by sparse  coding)       
(Zheng, Yao et al. 2015) ADNI HC vs AD (189 / 163) Cortical  thickness  in  78  ROI’s   (cor- APOE3. SVM (RBF) Sen = 0.899 / Spe = 0.943 
    HC vs MCI (189 / 198) relation matrix  representation,  FS  by     Sen = 0.878 / Spe = 0.858 
    MCI vs AD (198 / 163) mRMR  and  SVM-RFE).     Sen = 0.806 / Spe = 0.899 
    MCInc  vs MCIc  (94 / 104)       Sen = 0.789 / Spe = 0.799 
(Zheng, Shi et al. 2016) ADNI HC vs AD (52 / 51) GM volumes  and  PET intensity values PET. SVM (linear) Sen = 0.973 / Spe = 0.983 
      in  93  ROI’s  (high-level   representation       
      from multi-modality stacked deep poly-       
      nomial  network)       
(Zhou, Goryawala et al. 2014) ADNI HC vs AD (127 / 59) 41 regional  and  10 morphometric vol- MMSE. SVM (RBF) Sen = 0.840 / Spe = 0.961 
    HC vs MCIc  (127 / 67) umes (FS  by t-test).     Sen = 0.611 / Spe = 0.834 
    HC vs MCInc  (127 / 56)       Sen = 0.552 / Spe = 0.823 
(Zhu, Suk et al. 2014) ADNI HC vs AD (52 / 51) GM volumes  and  PET intensity values n.a. SVM Sen = 0.886 / Spe = 0.978 
    HC vs MCI (52 / 99) in  93  ROI’s  (FS  by  regularized  least     Sen = 0.948 / Spe = 0.569 
      square regression).       
(Zhu and Shi 2014) ADNI HC vs AD (52 / 51) GM  volumes  in  93  ROI’s  (co-training n.a. SVM (linear) Sen = 0.869 / Spe = 0.904 
      semi-supervised learning approach).       
(Zhu, Shi et al. 2014) ADNI HC vs AD (52 / 51) GM volumes  and  PET intensity values n.a. SVM (linear) Sen = 0.952 / Spe = 0.907 
      in 93 ROI’s (FS  by Hessian  regulariza-       
      tion  semi-supervised approach).       
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(Zhu, Suk et al. 2015) ADNI HC vs MCI vs AD GM volumes  and  PET intensity values PET. SMV Acc = 0.729 
    (52 / 99 / 51) in  93 ROI’s  (CCA  representation and       
    HC vs MCInc  vs MCIc  vs AD FS by multi-task learning).     Acc = 0.619 
    (52 / 56 / 43 / 51)         
 
Table S4. Machine learning methods for classification of other types of dementia. 
 
Reference Dataset Validation Tasks Imaging Imaging features Classifiers Acc 
  (population) set  size   sequences (FS  and  representation)     
(Chen, Tong et al. 2015) Local 350 / 240 HC  vs SVD CT Voxel  intensities in  ROI’s   from  WML-based MIL 0.75 
  (Stroke)       atlas.     
(Koikkalainen, Rhodius-Meester et al. 2016) Local 118 / 223 / 92 HC  vs AD  vs FTD T1w, FLAIR. Volumes  of  142  ROI’s,   values  of  TBM and Multimodal 0.706 
  (Dementia) / 47 / 24 vs DLB  vs SVD   VBM  in 140 ROI’s,  20 manifold learning fea- statistical   
          tures, 8  ROI-based gradings and   1  vascular approach.   
          burden measure.     
(Oppedal, Eftestøl et al. 2015) Local 36 / 57 / 16 HC  vs AD  vs LBD T1w, FLAIR. Voxel-wise 2D-LBP and contrast features from Random 0.87 
  (Dementia)       WM  amd  WML  regions  in  T1w  and  FLAIR forest.   
          (FS by best first approach).     
(Vemuri, Simon et al. 2011) Local 48 / 20 / 47 AD  vs FTD vs LBD T1w. GM volumes in 91 ROI’s (FS by LDA). k-means 0.867 
  (Dementia)             
(Wang, Redmond et al. 2016) Local 54 / 55 AD  vs FTD T1w. 17  neurophysiological features  and   GM  vol- Naive 0.6147 
  (Dementia) 57 / 54 / 55 HC  vs AD  vs FTD   umes   of  8  ROI’ss   (amygdala,  hippocampus, Bayes 0.6747 
          medial temporal lobe, temporal pole, dorsolat-     
          eral  prefrontal cortex, ventromedial prefrontal     
          cortex, striatum and  insula (FS  by  best  first     
          approach).     
 
 
 
Table S5: Machine learning studies on lesion segmentation; top, white matter 
hyperintensities; bottom, ischaemic stroke lesions. DC = DICE coefficient where a value close to 1 
indicates perfect match of the test segmentation with the reference standard and 0 indicates no overlap. 
 
Reference Dataset Validation Target Imaging Imaging  features Classifiers DC 
  (population) set  size   sequences (FS  and  representation)     
(Fiot, Cohen et al. 2013) Local 125 WMH T1w,  T2w, Neighbourhood  voxel   intensities  and   pyra- SVM (RBF) 0.69 
  (Ageing)     FLAIR, PD. midal  features (Gaussian kernels) from  each     
          modality in ROI’s.     
(Ithapu, Singh et al. 2014) Local 38 WMH T1w, FLAIR. Voxel intensities and textons in ROI’s. Random 0.67 
  (AD  and  ageing)         forest   
(Erus, Zacharaki et al. 2014) Local 80 WMH FLAIR. Voxel-wise   intensity  values   of  abnormality Iterative 0.59 
  (Diabetic       map in ROI’s (FS by wavelet-based approach). wavelet-based   
  and  ageing)         PCA model.   
(Griffanti, Zamboni et al. 2016) Local 82 WMH FLAIR. Spatially weighted voxel-wise intensity values, kNN 0.52 
  (TIA  or minor  stroke,       patch average intensity.     
  no lacunar infarcts)             
(Vos, Biesbroek et al. 2013) Local 30 Stroke CT. Location and  volume  of lesion,  voxel  intensi- Random 0.74 
  (Stroke)       ties  and  likelihood  of belonging  to  a lesion  in forest   
          lesion  and  mirrored region  (FS  by  first  best     
          search approach).     
(Guo, Fridriksson et al. 2015) Local 60 Stroke T1w. Voxel-wise  0-,  1-,  2-order  statistical features SVM 0.73 
  (Stroke)       from  T1w,  GM,  WM,  CSF  and  lesion  proba- (linear,   
          bility map. ensemble)   
(Maier, Schröder et al. 2015) Local 35 Stroke FLAIR. Voxel  intensity and  location, weighted mean Random 0.67 
  (spatial neglect)       and histogram in voxel neighbourhood. forest   
 
 
 
Table S 6.  Machine learning for detection of specific (small) lesions; top, microbleeds 
(CMB); bottom, lacunes. 
 
Reference Dataset Validation Target Imaging Imaging features Classifiers Pre Rec 
  (population) set size   sequences (FS and representation)       
(Ghafaryasl, van der Lijn et al. 2012) Local 81 CMB T2*, GRE. Intensity, size and shape features  from candi- Parzen,  QDC 0.352 0.99 
  (Ageing)       date ROI’s in T2*.  Intensity in GRE  (FS by       
          feed-forward approach).       
(Dou, Chen et al. 2016) Local 50 CMB SWI 3D patches of SWI used as input. 3D conv-NN 0.443 0.93 
  (Stroke  and ageing)               
(Fazlollahi, Meriaudeau et al. 2015) Local 66 CMB SWI 3D Radon-  and  Hessian-based  shape  features Random 0.101 0.87 
  (Diabetic       from candidate ROI’s. forest (cascade)     
  and ageing)               
(Uchiyama, Abe et al. 2014) Local 132 Stroke T1w, T2w Location,   intensity   differences  in  T1w  and SVM 0.154 0.97 
  (lacunar  infarcts)       T2w,  multi-scale  nodular  and  linear  compo-       
          nent (FS by PCA).       
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Figure S1 QUADAS-2 charts of the studies included in the review 
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Figure S2 – Forest plot of accuracy of studies for differentiating different cognitive states ordered by data source, 1st page.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2 continued– Forest plot of accuracy of studies for differentiating different cognitive states ordered by data source, 2nd page. 
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Figure S3 – Forest plot of accuracy of studies for differentiating different cognitive states ordered by machine learning method, 1st page. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S3 cont– Forest plot of accuracy of studies for differentiating different cognitive states ordered by machine learning method, 2nd 
page 
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Figure S4 – Forest plot of accuracy of studies for differentiating different cognitive states ordered by study size, 1st page. 
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Figure S4 continued – Forest plot of accuracy of studies for differentiating different cognitive states ordered by study size, 2nd page. 
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